The effects of ONO-3307 (4-sulfamoylphenyl 4-guanidinobenzoate methanesulfonate), a new synthetic protease inhibitor, on endotoxin-induced experimental disseminated intravascular coagulation (DIC) were studied in rats. Experimental DIC was induced by 4 hour sustained infusion of endotoxin at a dose of 100mg/kg. The rats were infused continuously with ONO-3307 at 1, 10, 100μg/kg/h into a femoral vein for 4 hour. Simultaneously with the agent infusion, endotoxin was administered into the contralateral femoral vein. A protective effect against DIC was noted in the rats treated with 10 or 100μg/kg/h of ONO-3307 in the following parameters: fibrinogen and fibrin degradation products, platelet count, fibrinogen level, prothrombin time, partial thromboplastin time and the number of renal glomeruli with fibrin thrombi. These results demonstrated that ONO-3307 reduces the extent of changes of the coagulation parameters caused by DIC.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (1989) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: